RECORD // Company

Axim Biotechnologies, Inc.

Formerly: AXIM INTERNATIONAL INC.

Built 2026-11-21T18:02:15Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (3)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Axim Biotechnologies · Ctgov · exact name match to 'AXIM BIOTECHNOLOGIES, INC.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • AXIM BIOTECHNOLOGIES, INC. · Ny corps · same registered legal name as 'AXIM BIOTECHNOLOGIES, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • AXIM BIOTECHNOLOGIES, INC. · USAspending · same registered legal name as 'AXIM BIOTECHNOLOGIES, INC.' Possible match based on name, not a shared identifier. Compare the records. Compare

4 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2024-06-30, filed 2024-08-19 · accession 0001096906-24-001772

Old data: this filer's newest 10-Q or 10-K in SEC company facts is for the period ended 2024-06-30. No later report has XBRL values.

ItemValuePeriodFormFiledAccessionReport
Revenue$17,4793 months ended 2024-06-3010-Q2024-08-190001096906-24-0017722026-11-21 18:02 UTCReport an error
Net income (loss)$-2,269,8153 months ended 2024-06-3010-Q2024-08-190001096906-24-0017722026-11-21 18:02 UTCReport an error
Interest expense$178,2443 months ended 2024-06-3010-Q2024-08-190001096906-24-0017722026-11-21 18:02 UTCReport an error
Cash and cash equivalents$6,044at 2024-06-3010-Q2024-08-190001096906-24-0017722026-11-21 18:02 UTCReport an error

Negative as reported in the filing.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0001514946
Ticker
AXIM
EIN
274092986
CUSIP
05463J107
Record ID
sx:sec:0001514946

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

18 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2024-12-06SEC EDGAR company profile2026-11-21 18:02 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2024-12-06SEC EDGAR company profile2026-11-21 18:02 UTCReport an error
State of incorporationNV2024-12-06SEC EDGAR company profile2026-11-21 18:02 UTCReport an error
Fiscal year end (MMDD)12312024-12-06SEC EDGAR company profile2026-11-21 18:02 UTCReport an error
Business address6191 CORNERSTONE COURT, E, SUITE 114, SAN DIEGO, CA, 921212024-12-06SEC EDGAR company profile2026-11-21 18:02 UTCReport an error
ExchangesOTC2024-12-06SEC EDGAR company profile2026-11-21 18:02 UTCReport an error
Revenue (fiscal year ended 2023-12-31)$39,5182023-12-3110-K, XBRL Revenues2026-11-21 18:02 UTCReport an error
Net income (loss) (fiscal year ended 2023-12-31)$-8,059,6822023-12-3110-K, XBRL NetIncomeLoss2026-11-21 18:02 UTCReport an error
Total assets (at 2023-12-31)$4,121,5482023-12-3110-K, XBRL Assets2026-11-21 18:02 UTCReport an error
Stockholders' equity (at 2023-12-31)$-7,656,6472023-12-3110-K, XBRL StockholdersEquity2026-11-21 18:02 UTCReport an error
Cash and cash equivalents (at 2023-12-31)$156,4572023-12-3110-K, XBRL CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents2026-11-21 18:02 UTCReport an error
Operating cash flow (fiscal year ended 2023-12-31)$-1,030,5002023-12-3110-K, XBRL NetCashProvidedByUsedInOperatingActivities2026-11-21 18:02 UTCReport an error
Capital expenditures (property, plant and equipment) (fiscal year ended 2023-12-31)$02023-12-3110-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment2026-11-21 18:02 UTCReport an error
Form D total offering amount (D filed 2020-06-15)$5,000,0002020-06-15D2026-11-21 18:02 UTCReport an error
Form D total amount sold (D filed 2020-06-15)$500,0002020-06-15D2026-11-21 18:02 UTCReport an error
Form D industry groupBiotechnology2020-06-15D2026-11-21 18:02 UTCReport an error
Form D revenue range$1 - $1,000,0002020-06-15D2026-11-21 18:02 UTCReport an error
Form D date of first sale2020-06-102020-06-15D2026-11-21 18:02 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.